MARKET

ARTHQ

ARTHQ

Arch Therapeutics Inc
EXMKT
0.0001
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
22.49
52 WEEK LOW
0.0001
MARKET CAP
444.44
P/E (TTM)
-0.0000
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ARTHQ last week (1124-1128)?
Weekly Report · 3d ago
Weekly Report: what happened at ARTHQ last week (1117-1121)?
Weekly Report · 11/24 09:00
Weekly Report: what happened at ARTHQ last week (1110-1114)?
Weekly Report · 11/17 09:00
Weekly Report: what happened at ARTHQ last week (1103-1107)?
Weekly Report · 11/10 09:00
Weekly Report: what happened at ARTHQ last week (1027-1031)?
Weekly Report · 11/03 09:00
Weekly Report: what happened at ARTHQ last week (1020-1024)?
Weekly Report · 10/27 09:00
Weekly Report: what happened at ARTHQ last week (1013-1017)?
Weekly Report · 10/20 09:00
Weekly Report: what happened at ARTHQ last week (1006-1010)?
Weekly Report · 10/13 09:00
More
About ARTHQ
Arch Therapeutics, Inc. is a biotechnology company developing and marketing products based on its AC5 self-assembling technology platform. These products can be advances in the field of stasis and barrier applications. The Company’s flagship products and product candidates are derived from its AC5 self-assembling peptide (SAP) technology platform and referred to as AC5 or the AC5 Devices. These include AC5 Advanced Wound System and AC5 Topical Hemostat, which are intended for skin applications, such as management of complicated chronic wounds and acute surgical wounds. Other products are in development for use in minimally invasive or open surgical procedures and include AC5-GTM for gastrointestinal endoscopic procedures and AC5-V and AC5 Surgical Hemostat for hemostasis inside the body. It is developing BioSurgery products for internal use, including for hemostasis and sealant applications, and gastrointestinal endoscopic surgical procedures.

Webull offers Arch Therapeutics Inc stock information, including EXMKT: ARTHQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARTHQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARTHQ stock methods without spending real money on the virtual paper trading platform.